Advanced technology in glycemic control and prevention of diabetes mellitus complications

Elena V. Biryukova

For citation:

Abstract

The review is focused on the issues of blood glucose self-monitoring for prevention of the diabetes mellitus complications. The data of clinical trials and actual clinical practice are provided that demonstrate improved quality of life and carbohydrate metabolism indicators in patients using advanced technology.
Key words: diabetes mellitus, carbohydrate metabolism, self-monitoring of blood glucose, hyperglycemia, hypoglycemia, complications.

References

1. URL: https: //diabetesatlas.org/

2. URL: https: //cdc.gov/diabetes/statistics/age/fig1.htm

3. Nathan DM. Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med. 2002; 347 (17): 1342–9. DOI: 10.1056/NEJMcp021106

4. Malmberg K, Yusuf S, Gerstein HC et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation. 2000; 102 (9): 1014–9. DOI: 10.1161/01.cir.102.9.1014

5. Booth GL et al. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet. 2006; 368: 29–36. DOI: 10.1016/S0140-6736 (06)68967-8

6. Morrish NJ et al. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001; 44 (Suppl. 2): 14–21.

7. Bauters C et al. Stress hyperglycaemia is an independent predictor of left ventricular remodelling after first anterior myocardial infarction in non-diabetic patients. Eur Heart J. 2007; 28: 546–52.

8. Дедов И.И., Шестакова М.В. Сахарный диабет и артериальная гипертензия. М., 2006.

Dedov II, Shestakova MV. Diabetes mellitus and arterial hypertension. Moscow, 2006 (in Russian).

9. Stratton IM, Adler AI, Neil HAW et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ. 2000; 321: 405. DOI: 10.1136/bmj.321.7258.405

10. Tahrani AA, Bailey CJ, Del Prato S, Barnett AH. Management of type 2 diabetes: new and future developments in treatment. Lancet. 2011; 378 (9786): 182–97. DOI: 10.1016/S0140-6736 (11)60207-9

11. Khunti K, Ceriello A, Cos X, De Block C. Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis. Diabetes Res Clin Pract. 2018 Mar; 137: 137–48. DOI: 10.1016/j.diabres.2017.12.004

12. Дедов И.И., Шестакова М.В., Викулова О.К. и др. Сахарный диабет в Российской Федерации: динамика эпидемиологических показателей по данным Федерального регистра сахарного диабета за период 2010–2022 гг. Сахарный диабет. 2023; 26 (2): 104–23. DOI: 10.14341/DM13035

Dedov II, Shestakova MV, Vikulova OK et al. Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022. Diabetes Mellitus. 2023; 26 (2): 104–23. DOI: 10.14341/DM13035 (in Russian).

13. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой,

А.Ю. Майорова. 11-й выпуск. М., 2023.

Standards of specialized diabetes care. Edited by I.I. Dedov, M.V. Shestakova, A.Yu. Mayorov. 11 Edition. Moscow, 2023 (in Russian).

14. American Diabetes Association Releases 2023 Standards of Care in Diabetes to Guide Prevention, Diagnosis, and Treatment for People Living with Diabetes. ADA, 2023.

15. Goldstein J, Mueller-Wieland Dirk. Type 2 Diabetes: Principles and Practice. 2008.

16. Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev. 2008; 24 (5): 353–63. DOI: 10.1002/dmrr.865

17. Chico A, Vidal-Ríos P, Subirà M, Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care. 2003; 26 (4): 1153–7. DOI: 10.2337/diacare.26.4. 1153

18. Weber KK, Lohmann T, Busch K et al. High frequency of unrecognized hypoglycaemias in patients with Type 2 diabetes is discovered by continuous glucose monitoring. Exp Clin Endocrinol Diabetes. 2007; 115 (8): 491–4. DOI: 10.1055/s-2007-984452

19. Zick R, Petersen B, Richter M, Haug C; SAFIR Study Group. Comparison of continuous blood glucose measurement with conventional documentation of hypoglycemia in patients with Type 2 diabetes on multiple daily insulin injection therapy. Diabetes Technol Ther. 2007; 9 (6): 483–92. DOI: 10.1089/dia.2007.0230

20. Сахарный диабет 2-го типа у взрослых. Клинические рекомендации Минздрава России. М., 2022. URL: https: //cr.minzdrav. gov.ru/recomend/290_2

Type 2 diabetes mellitus in adults. Clinical recommendations of the Ministry of Health of the Russian Federation. Moscow, 2022. URL: https: //cr.minzdrav.gov.ru/recomend/290_2 (in Russian).

21. American Diabetes Association Professional Practice Committee. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022; 45 (Suppl. 1): S125-S143. DOI: 10.2337/dc22-S009

22. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005; 54 (6): 1615–25. DOI: 10.2337/diabetes.54.6.1615

23. Monnier L. Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes? Eur J Clin Invest. 2000; 30 (Suppl 2): 3–11. PMID: 10975048.

24. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet. 1999; 354 (9179): 617–21.

25. Gapstur SM, Gann PH, Lowe W et al. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA. 2000; 283 (19): 2552–8. DOI: 10.1001/jama.283.19.2552

26. Ceriello A. The emerging challenge in diabetes: the "metabolic memory". Vascul Pharmacol. 2012; 57 (5–6): 133–8. DOI: 10.1016/j.vph. 2012.05.005

27. Sia HK, Kor CT, Tu ST et al. Self-monitoring of blood glucose in association with glycemic control in newly diagnosed non-insulin-treated diabetes patients: a retrospective cohort study. Sci Rep. 2021; 11 (1): 1176. DOI: 10.1038/s41598-021-81024-x

28. Karter AJ, Ackerson LM, Darbinian JA et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med. 2001; 111 (1): 1–9. DOI: 10.1016/s0002-9343 (01)00742-2

29. Эндокринология. Национальное руководство. Краткое издание. Под ред. И.И. Дедова, Г.А. Мельниченко. 2-е изд., перераб. и доп. М.: ГЭОТАР-Медиа, 2018.

Endocrinology. National leadership. A short edition. Edited by I.I. Dedov, G.A. Melnichenko. 2nd ed., revised and expanded. Moscow: GEOTAR-Media, 2018 (in Russian).

For citation:Biryukova E.V. Advanced technology in glycemic control and prevention of diabetes mellitus complications. Clinical review for general practice. 2023; 4 (10): 114–120 (In Russ.). DOI: 10.47407/kr2023.4.10.00351

All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Clinical review for general practice